Therefore, in addition to providing direct evidence for a role in diet-induced obesity, our findings suggest that treatments that inhibit EGFR activity may not only directly inhibit tumor growth but could have an additional effect to improve metabolic homeostasis. The gene discussed is EGFR; the disease is obesity disorder.